Separate and combined impact of albuminuria and kidney function on risk of coronary heart disease in the atherosclerosis risk in communities (ARIC) study

被引:0
|
作者
Astor, Brad C.
Hoogeveen, Ron C.
Steffes, Michael
Fulop, Tibor
Coresh, Josef
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Univ Minnesota, Minneapolis, MN USA
[4] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E266 / E267
页数:2
相关论文
共 50 条
  • [21] Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study
    Ballew, Shoshana H.
    Chen, Yan
    Daya, Natalie R.
    Godino, Job G.
    Windham, B. Gwen
    McAdams-DeMarco, Mara
    Coresh, Josef
    Selvin, Elizabeth
    Grams, Morgan E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (02) : 228 - 236
  • [22] Inflammation, Hemostasis, and the Risk of Kidney Function Decline in the Atherosclerosis Risk in Communities (ARIC) Study
    Bash, Lori D.
    Erlinger, Thomas P.
    Coresh, Josef
    Marsh-Manzi, Jane
    Folsom, Aaron R.
    Astor, Brad C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : 596 - 605
  • [23] Combined Association of Albuminuria and Cystatin C-Based Estimated GFR With Mortality, Coronary Heart Disease, and Heart Failure Outcomes: The Atherosclerosis Risk in Communities (ARIC) Study
    Waheed, Salman
    Matsushita, Kunihiro
    Sang, Yingying
    Hoogeveen, Ron
    Ballantyne, Christie
    Coresh, Josef
    Astor, Brad C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (02) : 207 - 216
  • [24] Metabolic Risk Transitions In Obesity With The Incidence Of Heart Failure And Coronary Heart Disease: The Atherosclerosis Risk In Communities (aric) Study
    Commodore-Mensah, Yvonne
    Zhang, Sui
    Tcheugui, Justin Echouffo
    Florido, Roberta
    Nambi, Vijay
    Michos, Erin D.
    Post, Wendy S.
    Gerstenblith, Gary
    Blumenthal, Roger S.
    Ballantyne, Christie M.
    Selvin, Elizabeth
    Ndumele, Chiadi E.
    CIRCULATION, 2022, 145
  • [25] Glycemic control and coronary heart disease risk in persons with and without diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
    Selvin, E
    Coresh, J
    Golden, SH
    Brancati, FL
    Folsom, AR
    Steffes, MW
    CIRCULATION, 2005, 111 (14) : E199 - E199
  • [26] Validation of death certificate diagnosis for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study
    Coady, SA
    Sorlie, PD
    Cooper, LS
    Folsom, AR
    Rosamond, WD
    Conwill, DE
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (01) : 40 - 50
  • [27] Peripheral artery disease and risk of kidney outcomes: The Atherosclerosis Risk in Communities (ARIC) study
    Paskiewicz, Amy
    Wang, Frances M.
    Ishigami, Junichi
    Pang, Yuanjie
    Sang, Yingying
    Ballew, Shoshana H.
    Grams, Morgan E.
    Heiss, Gerardo
    Coresh, Josef
    Matsushita, Kunihiro
    ATHEROSCLEROSIS, 2024, 397
  • [28] Anemia, Chronic Kidney Disease, and Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study
    Ishigami, Junichi
    Grams, Morgan E.
    Naik, Rakhi P.
    Caughey, Melissa C.
    Loehr, Laura R.
    Coresh, Josef
    Matsushita, Kunihiro
    CIRCULATION, 2016, 133
  • [29] Soluble thrombomodulin as a predictor of incident coronary heart disease: The atherosclerosis risk in communities (ARIC) study
    Salomaa, VV
    Matel, C
    Aleksic, N
    Sansores-Garcia, L
    Folsom, AR
    Juneja, H
    Chambless, LE
    Wu, KK
    CIRCULATION, 1998, 98 (17) : 524 - 524
  • [30] Prospective study of fibrinolytic factors and incident coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study
    Folsom, AR
    Aleksik, N
    Park, E
    Salomaa, V
    Juneja, H
    Wu, KK
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 611 - 617